Get Your Free Curia Report Now
Download The Report7 Stocks to Cut Through the Noise
And the advantage they give investors like you in 2025 and beyond
When you access the report, you also get Curia Review (our free email newsletter) as well as Curia Now (our weekly video roundtable).
This report, available exclusively at Curia Financial, features seven fresh investment ideas from Curia experts Simon Erickson and James Early, as well as special guest Pieter Slegers of Compounding Quality.
What's Included
-
1. A tiny, risky biotech whose immunotherapy treatment has more than doubled progression-free survival in certain cancers in trials.
-
2. A company whose product is “more addictive than cigarettes” - with a stock that's up 4,700% since its IPO.
-
3. A little-known advertising powerhouse that one expert says is trading for half off thanks to tariff fears.
-
4. A boring, steady electric utility that just expanded its nuclear arsenal.
-
5. A company that makes your kid's (and your chef's) favorite shoes - and which is trading at a bargain 6x cash flow.
-
6. A niche insurance company that looks a lot like GEICO - one of Warren Buffett's best investments - did 40 years ago.
-
7. A simple, one-click move you can make to reduce your ETF risk if you're holding an S&P 500 ETF like SPY or VOO.
James Early
James Early is CEO of Curia and its Editor-in-Chief. James is the former Director of Research & Analysis for The Motley Fool, CEO of Stansberry China, and Chief Investment Officer of BBAE. James' Motley Fool Income Investor research product beat the S&P 500 10 out of 10 years in a row. James is a frequent guest in national and international media.
Simon Erickson
Simon Erickson heads Curia's growth investing division. Simon is the former lead advisor for Motley Fool Explorer and founder of 7investing, with a broad business background including stints at General Electric, Waste Management, and Chevron. Simon was an early investor in Nvidia, Bitcoin, and Tesla.
Subscribe